 | • レポートコード：MRC2102QY15934 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、130ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界の弱毒生水痘ワクチン市場について種類別（一価ワクチン、混合ワクチン）、用途別（子供用注射薬、成人用注射薬）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・弱毒生水痘ワクチン市場の概要 ・世界の主要地域別弱毒生水痘ワクチン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の弱毒生水痘ワクチン市場規模2015-2026：種類別（一価ワクチン、混合ワクチン） ・世界の弱毒生水痘ワクチン市場規模2015-2026：用途別（子供用注射薬、成人用注射薬） ・弱毒生水痘ワクチンの米国市場規模2015-2020 ・弱毒生水痘ワクチンのヨーロッパ市場規模2015-2020 ・弱毒生水痘ワクチンの中国市場規模2015-2020 ・弱毒生水痘ワクチンの日本市場規模2015-2020 ・弱毒生水痘ワクチンの東南アジア市場規模2015-2020 ・弱毒生水痘ワクチンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・弱毒生水痘ワクチンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・弱毒生水痘ワクチンの市場動向・機会・課題 ・調査の結論 |
A live attenuated varicella vaccine, derived from the Oka strain of VZV has clinical efficacy for the prevention of varicella.
The downstream industries of varicella attenuated live vaccine products are kids and adults. In the recent years, with the recovery of global economic, the development of emerging countries and the rising health concern, the consumption increase of varicella attenuated live vaccine will be obvious. In the foreseeable future, the varicella attenuated live vaccine products will show an optimistic upward trend.
Market Analysis and Insights: Global Varicella Attenuated Live Vaccine Market
The global Varicella Attenuated Live Vaccine market size is projected to reach US$ 3324.3 million by 2026, from US$ 2118.3 million in 2020, at a CAGR of 7.8% during 2021-2026.
Global Varicella Attenuated Live Vaccine Scope and Market Size
The global Varicella Attenuated Live Vaccine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Varicella Attenuated Live Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Varicella Attenuated Live Vaccine market is segmented into
Monovalent Vaccine
Combination Vaccine
Segment by Application, the Varicella Attenuated Live Vaccine market is segmented into
Kids Injection
Adults Injection
The Varicella Attenuated Live Vaccine market is analysed and market size information is provided by regions (countries). Segment by Application, the Varicella Attenuated Live Vaccine market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Varicella Attenuated Live Vaccine Market Share Analysis
Varicella Attenuated Live Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Varicella Attenuated Live Vaccine business, the date to enter into the Varicella Attenuated Live Vaccine market, Varicella Attenuated Live Vaccine product introduction, recent developments, etc.
The major vendors covered:
Merck
GSK
BCHT
Changsheng
Keygen
Green Cross
Biken
1 Varicella Attenuated Live Vaccine Market Overview
1.1 Varicella Attenuated Live Vaccine Product Scope
1.2 Varicella Attenuated Live Vaccine Segment by Type
1.2.1 Global Varicella Attenuated Live Vaccine Sales by Type (2020-2026)
1.2.2 Monovalent Vaccine
1.2.3 Combination Vaccine
1.3 Varicella Attenuated Live Vaccine Segment by Application
1.3.1 Global Varicella Attenuated Live Vaccine Sales Comparison by Application (2020-2026)
1.3.2 Kids Injection
1.3.3 Adults Injection
1.4 Varicella Attenuated Live Vaccine Market Estimates and Forecasts (2015-2026)
1.4.1 Global Varicella Attenuated Live Vaccine Sales Growth Rate (2015-2026)
1.4.2 Global Varicella Attenuated Live Vaccine Revenue and Growth Rate (2015-2026)
1.4.3 Global Varicella Attenuated Live Vaccine Price Trends (2015-2026)
2 Varicella Attenuated Live Vaccine Estimate and Forecast by Region
2.1 Global Varicella Attenuated Live Vaccine Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Varicella Attenuated Live Vaccine Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Varicella Attenuated Live Vaccine Sales Market Share by Region (2015-2020)
2.2.2 Global Varicella Attenuated Live Vaccine Revenue Market Share by Region (2015-2020)
2.3 Global Varicella Attenuated Live Vaccine Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Varicella Attenuated Live Vaccine Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Varicella Attenuated Live Vaccine Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Varicella Attenuated Live Vaccine Estimates and Projections (2015-2026)
2.4.2 Europe Varicella Attenuated Live Vaccine Estimates and Projections (2015-2026)
2.4.3 China Varicella Attenuated Live Vaccine Estimates and Projections (2015-2026)
2.4.4 Japan Varicella Attenuated Live Vaccine Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Varicella Attenuated Live Vaccine Estimates and Projections (2015-2026)
2.4.6 India Varicella Attenuated Live Vaccine Estimates and Projections (2015-2026)
3 Global Varicella Attenuated Live Vaccine Competition Landscape by Players
3.1 Global Top Varicella Attenuated Live Vaccine Players by Sales (2015-2020)
3.2 Global Top Varicella Attenuated Live Vaccine Players by Revenue (2015-2020)
3.3 Global Varicella Attenuated Live Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Varicella Attenuated Live Vaccine as of 2019)
3.4 Global Varicella Attenuated Live Vaccine Average Price by Company (2015-2020)
3.5 Manufacturers Varicella Attenuated Live Vaccine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Varicella Attenuated Live Vaccine Players (Opinion Leaders)
4 Global Varicella Attenuated Live Vaccine Market Size by Type
4.1 Global Varicella Attenuated Live Vaccine Historic Market Review by Type (2015-2020)
4.1.1 Global Varicella Attenuated Live Vaccine Sales Market Share by Type (2015-2020)
4.1.2 Global Varicella Attenuated Live Vaccine Revenue Market Share by Type (2015-2020)
4.1.3 Global Varicella Attenuated Live Vaccine Price by Type (2015-2020)
4.2 Global Varicella Attenuated Live Vaccine Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Varicella Attenuated Live Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Varicella Attenuated Live Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Global Varicella Attenuated Live Vaccine Price Forecast by Type (2021-2026)
5 Global Varicella Attenuated Live Vaccine Market Size by Application
5.1 Global Varicella Attenuated Live Vaccine Historic Market Review by Application (2015-2020)
5.1.1 Global Varicella Attenuated Live Vaccine Sales Market Share by Application (2015-2020)
5.1.2 Global Varicella Attenuated Live Vaccine Revenue Market Share by Application (2015-2020)
5.1.3 Global Varicella Attenuated Live Vaccine Price by Application (2015-2020)
5.2 Global Varicella Attenuated Live Vaccine Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Varicella Attenuated Live Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Varicella Attenuated Live Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Varicella Attenuated Live Vaccine Price Forecast by Application (2021-2026)
6 United States Varicella Attenuated Live Vaccine Market Facts & Figures
6.1 United States Varicella Attenuated Live Vaccine Sales Market Share by Company (2015-2020)
6.2 United States Varicella Attenuated Live Vaccine Sales Market Share by Type (2015-2020)
6.3 United States Varicella Attenuated Live Vaccine Sales Market Share by Application (2015-2020)
7 Europe Varicella Attenuated Live Vaccine Market Facts & Figures
7.1 Europe Varicella Attenuated Live Vaccine Sales Market Share by Company (2015-2020)
7.2 Europe Varicella Attenuated Live Vaccine Sales Market Share by Type (2015-2020)
7.3 Europe Varicella Attenuated Live Vaccine Sales Market Share by Application (2015-2020)
8 China Varicella Attenuated Live Vaccine Market Facts & Figures
8.1 China Varicella Attenuated Live Vaccine Sales Market Share by Company (2015-2020)
8.2 China Varicella Attenuated Live Vaccine Sales Market Share by Type (2015-2020)
8.3 China Varicella Attenuated Live Vaccine Sales Market Share by Application (2015-2020)
9 Japan Varicella Attenuated Live Vaccine Market Facts & Figures
9.1 Japan Varicella Attenuated Live Vaccine Sales Market Share by Company (3015-3030)
9.2 Japan Varicella Attenuated Live Vaccine Sales Market Share by Type (2015-2020)
9.3 Japan Varicella Attenuated Live Vaccine Sales Market Share by Application (2015-2020)
10 Southeast Asia Varicella Attenuated Live Vaccine Market Facts & Figures
10.1 Southeast Asia Varicella Attenuated Live Vaccine Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Varicella Attenuated Live Vaccine Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Varicella Attenuated Live Vaccine Sales Market Share by Application (2015-2020)
11 India Varicella Attenuated Live Vaccine Market Facts & Figures
11.1 India Varicella Attenuated Live Vaccine Sales Market Share by Company (2015-2020)
11.2 India Varicella Attenuated Live Vaccine Sales Market Share by Type (2015-2020)
11.3 India Varicella Attenuated Live Vaccine Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Varicella Attenuated Live Vaccine Business
12.1 Merck
12.1.1 Merck Corporation Information
12.1.2 Merck Business Overview
12.1.3 Merck Varicella Attenuated Live Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Merck Varicella Attenuated Live Vaccine Products Offered
12.1.5 Merck Recent Development
12.2 GSK
12.2.1 GSK Corporation Information
12.2.2 GSK Business Overview
12.2.3 GSK Varicella Attenuated Live Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.2.4 GSK Varicella Attenuated Live Vaccine Products Offered
12.2.5 GSK Recent Development
12.3 BCHT
12.3.1 BCHT Corporation Information
12.3.2 BCHT Business Overview
12.3.3 BCHT Varicella Attenuated Live Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.3.4 BCHT Varicella Attenuated Live Vaccine Products Offered
12.3.5 BCHT Recent Development
12.4 Changsheng
12.4.1 Changsheng Corporation Information
12.4.2 Changsheng Business Overview
12.4.3 Changsheng Varicella Attenuated Live Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Changsheng Varicella Attenuated Live Vaccine Products Offered
12.4.5 Changsheng Recent Development
12.5 Keygen
12.5.1 Keygen Corporation Information
12.5.2 Keygen Business Overview
12.5.3 Keygen Varicella Attenuated Live Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Keygen Varicella Attenuated Live Vaccine Products Offered
12.5.5 Keygen Recent Development
12.6 Green Cross
12.6.1 Green Cross Corporation Information
12.6.2 Green Cross Business Overview
12.6.3 Green Cross Varicella Attenuated Live Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Green Cross Varicella Attenuated Live Vaccine Products Offered
12.6.5 Green Cross Recent Development
12.7 Biken
12.7.1 Biken Corporation Information
12.7.2 Biken Business Overview
12.7.3 Biken Varicella Attenuated Live Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Biken Varicella Attenuated Live Vaccine Products Offered
12.7.5 Biken Recent Development
…
13 Varicella Attenuated Live Vaccine Manufacturing Cost Analysis
13.1 Varicella Attenuated Live Vaccine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Varicella Attenuated Live Vaccine
13.4 Varicella Attenuated Live Vaccine Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Varicella Attenuated Live Vaccine Distributors List
14.3 Varicella Attenuated Live Vaccine Customers
15 Market Dynamics
15.1 Varicella Attenuated Live Vaccine Market Trends
15.2 Varicella Attenuated Live Vaccine Opportunities and Drivers
15.3 Varicella Attenuated Live Vaccine Market Challenges
15.4 Varicella Attenuated Live Vaccine Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Varicella Attenuated Live Vaccine Sales (K Doses) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Varicella Attenuated Live Vaccine Sales (K Doses) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Varicella Attenuated Live Vaccine Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Varicella Attenuated Live Vaccine Sales (K Doses) by Region (2015-2020)
Table 5. Global Varicella Attenuated Live Vaccine Sales Market Share by Region (2015-2020)
Table 6. Global Varicella Attenuated Live Vaccine Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Varicella Attenuated Live Vaccine Revenue Share by Region (2015-2020)
Table 8. Global Varicella Attenuated Live Vaccine Sales (K Doses) Forecast by Region (2021-2026)
Table 9. Global Varicella Attenuated Live Vaccine Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Varicella Attenuated Live Vaccine Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Varicella Attenuated Live Vaccine Revenue Share Forecast by Region (2021-2026)
Table 12. Global Varicella Attenuated Live Vaccine (K Doses) of Key Companies (2015-2020)
Table 13. Global Varicella Attenuated Live Vaccine Sales Share by Company (2015-2020)
Table 14. Global Varicella Attenuated Live Vaccine Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Varicella Attenuated Live Vaccine Revenue Share by Company (2015-2020)
Table 16. Global Varicella Attenuated Live Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Varicella Attenuated Live Vaccine as of 2019)
Table 17. Global Varicella Attenuated Live Vaccine Average Price (USD/Dose) of Key Company (2015-2020)
Table 18. Manufacturers Varicella Attenuated Live Vaccine Manufacturing Sites and Area Served
Table 19. Manufacturers Varicella Attenuated Live Vaccine Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Varicella Attenuated Live Vaccine Players
Table 22. Global Varicella Attenuated Live Vaccine Sales (K Doses) by Type (2015-2020)
Table 23. Global Varicella Attenuated Live Vaccine Sales Share by Type (2015-2020)
Table 24. Global Varicella Attenuated Live Vaccine Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Varicella Attenuated Live Vaccine Price (K Doses) by Type (2015-2020)
Table 26. Global Varicella Attenuated Live Vaccine Sales Share by Type (2021-2026)
Table 27. Global Varicella Attenuated Live Vaccine Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Varicella Attenuated Live Vaccine Revenue Share by Type (2021-2026)
Table 29. Global Varicella Attenuated Live Vaccine Price (K Doses) by Type (2021-2026)
Table 30. Global Varicella Attenuated Live Vaccine Sales (K Doses) by Application (2015-2020)
Table 31. Global Varicella Attenuated Live Vaccine Sales Share by Application (2015-2020)
Table 32. Global Varicella Attenuated Live Vaccine Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Varicella Attenuated Live Vaccine Price (K Doses) by Application (2015-2020)
Table 34. Global Varicella Attenuated Live Vaccine Sales (K Doses) by Application (2021-2026)
Table 35. Global Varicella Attenuated Live Vaccine Sales Share by Application (2021-2026)
Table 36. Global Varicella Attenuated Live Vaccine Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Varicella Attenuated Live Vaccine Revenue Share by Application (2021-2026)
Table 38. Global Varicella Attenuated Live Vaccine Price (K Doses) by Application (2021-2026)
Table 39. United States Varicella Attenuated Live Vaccine Sales (K Doses) by Company (2015-2020)
Table 40. United States Varicella Attenuated Live Vaccine Sales Market Share by Company (2015-2020)
Table 41. United States Varicella Attenuated Live Vaccine Sales (K Doses) by Type (2015-2020)
Table 42. United States Varicella Attenuated Live Vaccine Sales Market Share by Type (2015-2020)
Table 43. United States Varicella Attenuated Live Vaccine Sales (K Doses) by Application (2015-2020)
Table 44. United States Varicella Attenuated Live Vaccine Sales Market Share by Application (2015-2020)
Table 45. Europe Varicella Attenuated Live Vaccine Sales (K Doses) by Company (2015-2020)
Table 46. Europe Varicella Attenuated Live Vaccine Sales Market Share by Company (2015-2020)
Table 47. Europe Varicella Attenuated Live Vaccine Sales (K Doses) by Type (2015-2020)
Table 48. Europe Varicella Attenuated Live Vaccine Sales Market Share by Type (2015-2020)
Table 49. Europe Varicella Attenuated Live Vaccine Sales (K Doses) by Application (2015-2020)
Table 50. Europe Varicella Attenuated Live Vaccine Sales Market Share by Type (2015-2020)
Table 51. China Varicella Attenuated Live Vaccine Sales (K Doses) by Company (2015-2020)
Table 52. China Varicella Attenuated Live Vaccine Sales Market Share by Company (2015-2020)
Table 53. China Varicella Attenuated Live Vaccine Sales (K Doses) by Type (2015-2020)
Table 54. China Varicella Attenuated Live Vaccine Sales Market Share by Type (2015-2020)
Table 55. China Varicella Attenuated Live Vaccine Sales (K Doses) by Application (2015-2020)
Table 56. China Varicella Attenuated Live Vaccine Sales Market Share by Application (2015-2020)
Table 57. Japan Varicella Attenuated Live Vaccine Sales (K Doses) by Company (2015-2020)
Table 58. Japan Varicella Attenuated Live Vaccine Sales Market Share by Company (2015-2020)
Table 59. Japan Varicella Attenuated Live Vaccine Sales (K Doses) by Type (2015-2020)
Table 60. Japan Varicella Attenuated Live Vaccine Sales Market Share by Type (2015-2020)
Table 61. Japan Varicella Attenuated Live Vaccine Sales (K Doses) by Application (2015-2020)
Table 62. Japan Varicella Attenuated Live Vaccine Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Varicella Attenuated Live Vaccine Sales (K Doses) by Company (2015-2020)
Table 64. Southeast Asia Varicella Attenuated Live Vaccine Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Varicella Attenuated Live Vaccine Sales (K Doses) by Type (2015-2020)
Table 66. Southeast Asia Varicella Attenuated Live Vaccine Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Varicella Attenuated Live Vaccine Sales (K Doses) by Type (2015-2020)
Table 68. Southeast Asia Varicella Attenuated Live Vaccine Sales Market Share by Application (2015-2020)
Table 69. India Varicella Attenuated Live Vaccine Sales (K Doses) by Company (2015-2020)
Table 70. India Varicella Attenuated Live Vaccine Sales Market Share by Company (2015-2020)
Table 71. India Varicella Attenuated Live Vaccine Sales (K Doses) by Type (2015-2020)
Table 72. India Varicella Attenuated Live Vaccine Sales Market Share by Type (2015-2020)
Table 73. India Varicella Attenuated Live Vaccine Sales (K Doses) by Application (2015-2020)
Table 74. India Varicella Attenuated Live Vaccine Sales Market Share by Application (2015-2020)
Table 75. Merck Corporation Information
Table 76. Merck Description and Business Overview
Table 77. Merck Varicella Attenuated Live Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 78. Merck Varicella Attenuated Live Vaccine Product
Table 79. Merck Recent Development
Table 80. GSK Corporation Information
Table 81. GSK Description and Business Overview
Table 82. GSK Varicella Attenuated Live Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 83. GSK Varicella Attenuated Live Vaccine Product
Table 84. GSK Recent Development
Table 85. BCHT Corporation Information
Table 86. BCHT Description and Business Overview
Table 87. BCHT Varicella Attenuated Live Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 88. BCHT Varicella Attenuated Live Vaccine Product
Table 89. BCHT Recent Development
Table 90. Changsheng Corporation Information
Table 91. Changsheng Description and Business Overview
Table 92. Changsheng Varicella Attenuated Live Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 93. Changsheng Varicella Attenuated Live Vaccine Product
Table 94. Changsheng Recent Development
Table 95. Keygen Corporation Information
Table 96. Keygen Description and Business Overview
Table 97. Keygen Varicella Attenuated Live Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 98. Keygen Varicella Attenuated Live Vaccine Product
Table 99. Keygen Recent Development
Table 100. Green Cross Corporation Information
Table 101. Green Cross Description and Business Overview
Table 102. Green Cross Varicella Attenuated Live Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 103. Green Cross Varicella Attenuated Live Vaccine Product
Table 104. Green Cross Recent Development
Table 105. Biken Corporation Information
Table 106. Biken Description and Business Overview
Table 107. Biken Varicella Attenuated Live Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 108. Biken Varicella Attenuated Live Vaccine Product
Table 109. Biken Recent Development
Table 110. Production Base and Market Concentration Rate of Raw Material
Table 111. Key Suppliers of Raw Materials
Table 112. Varicella Attenuated Live Vaccine Distributors List
Table 113. Varicella Attenuated Live Vaccine Customers List
Table 114. Varicella Attenuated Live Vaccine Market Key Trends
Table 115. Varicella Attenuated Live Vaccine Key Opportunities and Drivers
Table 116. Varicella Attenuated Live Vaccine Market Challenges
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Varicella Attenuated Live Vaccine Product Picture
Figure 2. Global Varicella Attenuated Live Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Varicella Attenuated Live Vaccine Market Share by Application in 2020 & 2026
Figure 6. Kids Injection Examples
Figure 7. Adults Injection Examples
Figure 8. Global Varicella Attenuated Live Vaccine Sales (K Doses) Growth Rate (2015-2026)
Figure 9. Global Varicella Attenuated Live Vaccine Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Varicella Attenuated Live Vaccine Price Trends Growth Rate (2015-2026) (USD/Dose)
Figure 11. Global Varicella Attenuated Live Vaccine Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Varicella Attenuated Live Vaccine Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Varicella Attenuated Live Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Varicella Attenuated Live Vaccine Sales (K Doses) Growth Rate (2015-2026)
Figure 15. Europe Varicella Attenuated Live Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Varicella Attenuated Live Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Varicella Attenuated Live Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Varicella Attenuated Live Vaccine Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Varicella Attenuated Live Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Varicella Attenuated Live Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Varicella Attenuated Live Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Varicella Attenuated Live Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Varicella Attenuated Live Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Varicella Attenuated Live Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Varicella Attenuated Live Vaccine Players Market Share by Revenue in Varicella Attenuated Live Vaccine 2015 & 2019
Figure 26. Varicella Attenuated Live Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Varicella Attenuated Live Vaccine Revenue Share by Type (2015-2020)
Figure 28. Global Varicella Attenuated Live Vaccine Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Varicella Attenuated Live Vaccine Revenue Share by Application (2015-2020)
Figure 30. Global Varicella Attenuated Live Vaccine Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Varicella Attenuated Live Vaccine Sales Market Share by Type in 2019
Figure 32. United States Varicella Attenuated Live Vaccine Sales Market Share by Type in 2019
Figure 33. Europe Varicella Attenuated Live Vaccine Sales Market Share by Company in 2019
Figure 34. Europe Varicella Attenuated Live Vaccine Sales Market Share by Type in 2019
Figure 35. Europe Varicella Attenuated Live Vaccine Sales Market Share by Application in 2019
Figure 36. China Varicella Attenuated Live Vaccine Sales Market Share by Company in 2019
Figure 37. China Varicella Attenuated Live Vaccine Sales Market Share by Type in 2019
Figure 38. China Varicella Attenuated Live Vaccine Sales Market Share by Application in 2019
Figure 39. Japan Varicella Attenuated Live Vaccine Sales Market Share by Company in 2019
Figure 40. Japan Varicella Attenuated Live Vaccine Sales Market Share by Type in 2019
Figure 41. Japan Varicella Attenuated Live Vaccine Sales Market Share by Application in 2019
Figure 42. Southeast Asia Varicella Attenuated Live Vaccine Sales Market Share by Company in 2019
Figure 43. Southeast Asia Varicella Attenuated Live Vaccine Sales Market Share by Type in 2019
Figure 44. Southeast Asia Varicella Attenuated Live Vaccine Sales Market Share by Application in 2019
Figure 45. India Varicella Attenuated Live Vaccine Sales Market Share by Company in 2019
Figure 46. India Varicella Attenuated Live Vaccine Sales Market Share by Type in 2019
Figure 47. India Varicella Attenuated Live Vaccine Sales Market Share by Application in 2019
Figure 48. Key Raw Materials Price Trend
Figure 49. Manufacturing Cost Structure of Varicella Attenuated Live Vaccine
Figure 50. Manufacturing Process Analysis of Varicella Attenuated Live Vaccine
Figure 51. Varicella Attenuated Live Vaccine Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Porter's Five Forces Analysis
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
弱毒生ワクチンの世界市場レポート2020 Live attenuated vaccine refers to the pathogen after formaldehyde treatment, the structure of A subunit (toxic subunit) changes, toxicity weakened, but the activity of B subunit (binding subunit) remains unchanged, that is, the antigenicity of A vaccine. Inoculation into the body will not cause dise…- 水痘ワクチンの世界市場レポート2020 Varicella vaccine, also known as chickenpox vaccine, is a vaccine that protects against chickenpox. One dose of vaccine prevents 95% of moderate disease and 100% of severe disease. Two doses of vaccine is more effective than one. If given to those who are not immune within five days of exposure to c…
- 水痘（水疱瘡）ワクチンの世界市場レポート2020 Market Analysis and Insights: Global Chickenpox (Varicella) Vaccine Market The global Chickenpox (Varicella) Vaccine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Chickenpox (Varicella) Vaccine Scope and Market Size T…
- 麻疹（はしか）ワクチンの世界市場レポート2020 Measles vaccine is made by inoculation of attenuated strain of measles virus into chicken embryo cells, culture and harvesting of virus venom, and then freeze-drying. Injection into the lateral deltoid muscle attachment of the upper arm can prevent measles. Market Analysis and Insights: Global Measl…
- ヒト用ワクチンの世界市場レポート2020 A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. China …